New drug firm limits prompt fears of falloff in medical meetings in city
Boston's status as a popular destination for medical industry meetings - which generate tens of millions of dollars in revenue for hotels, restaurants, and the state - is at risk because of new regulations restricting financial relationships between pharmaceutical companies and doctors, according to industry executives. (Full article: 993 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
